Using autologous blood as raw material, it reacts with precise and quantitative trioxygen gas in vitro before being reintroduced into the body. This process helps treat various diseases and enhances the body's functional state by oxidizing, inducing, and activating the metabolism and functionality of tissues and organs within the circulatory and immune systems.

Unlike traditional manual PRP collection, Nigale's next-generation blood component separator (HDS928) efficiently collects "concentrated platelets" rich in over a dozen regenerative factors. This high-concentration component derived from autologous blood possesses potent tissue regeneration and repair capabilities.

Adopt Nigale's next-generation equipment. Adopt Fresenius's next-generation equipment (imported from Germany).

Offer advanced cell and exosome therapy technologies for disease prevention and anti-aging. The laboratory conducts cell viability and sterility testing following strict standards, offers comprehensive cell testing and biosafety assessments, and utilizes a component-limited medium to minimize the risk of allergic reactions.